Indication for Frovatriptan

Population group: Suitable for both men and women, only adults (18 years old or older)
Therapeutic intent: Curative procedure

Acute treatment of the headache phase of migraine attacks with or without aura.

For this indication, competent medicine agencies globally authorize below treatments:

2.5-5.0 mg in 1-2 divided doses daily

Route of admnistration


Defined daily dose

2.5 - 5 mg

Dosage regimen

From 2.5 To 5 mg once every day

Detailed description

Frovatriptan should be taken as early as possible after the onset of a migraine attack but it is also effective when taken at a later stage. Frovatriptan should not be used prophylactically.

If a patient does not respond to the first dose of frovatriptan, a second dose should not be taken for the same attack, since no benefit has been shown.

Frovatriptan may be used for subsequent migraine attacks.

The recommended dose of frovatriptan is 2.5 mg.

If the migraine recurs after initial relief, a second dose may be taken, providing there is an interval of at least 2 hours between the two doses.

The total daily dose should not exceed 5 mg per day.

Dosage considerations

The frovatriptan tablets should be swallowed whole with water.

Active ingredient

Frovatriptan is a selective agonist for 5-HT receptors. Frovatriptan is believed to act selectively on extracerebral, intracranial arteries to inhibit the excessive dilatation of these vessels in migraine.

Read more about Frovatriptan

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner